Dominari Holdings Inc. (NASDAQ:DOMH) Sees Large Increase in Short Interest

Dominari Holdings Inc. (NASDAQ:DOMH) was the target of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 41,200 shares, a growth of 396.4% from the December 15th total of 8,300 shares. Currently, 1.2% of the shares of the company are short sold. Based on an average trading volume of 27,200 shares, the days-to-cover ratio is presently 1.5 days.

Dominari Trading Up 2.4 %

Shares of DOMH traded up $0.03 during trading hours on Wednesday, reaching $1.06. 18,813 shares of the stock traded hands, compared to its average volume of 69,090. Dominari has a 52-week low of $0.83 and a 52-week high of $3.20. The company has a market cap of $6.68 million, a P/E ratio of -0.27 and a beta of 1.03. The company’s 50-day moving average price is $1.44 and its two-hundred day moving average price is $1.66.

Dominari (NASDAQ:DOMH) last released its quarterly earnings data on Friday, November 8th. The company reported ($0.45) earnings per share for the quarter. Dominari had a negative return on equity of 32.89% and a negative net margin of 180.22%. The business had revenue of $4.04 million during the quarter.

Dominari Company Profile

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.